Oxidative stress in myocardial ischaemia reperfusion injury: a renewed focus on a long-standing area of heart research.
Advances in the treatment of coronary artery disease have seen a significant drop in mortality and morbidity particularly amongst patients with acute myocardial infarction (MI). In particular, percutaneous trans-luminal balloon angioplasty (PTCA) with stenting to re-open atherosclerotic coronary arteries has yielded marked improvement in clinical outcome for patients with acute MI. Furthermore, with the advent of drug-eluting stents occurrence rates for coronary artery restenosis, one common clinical problem associated with angioplasty and stent deployment, have declined markedly. However, coronary restenosis in diabetic patients remains an on-going problem. The success of drug-eluting stents has seen a renewed focus on myocardial ischaemia reperfusion (IR) injury as this represents one area of research where many questions remain unanswered. In particular, the relationship between myocardial IR injury and decreased myocardial micro-vasculature re-flow post PTCA (that ultimately leads to poor clinical outcome and myocardial damage/dysfunction) is one area of research with the potential to decrease current complication rates further in patients suffering myocardial IR injury sustained during MI. This review discusses the role for oxidative stress, oxidant source(s) and both gene regulation and stem-cell therapy as potential strategic targets in the ischaemic myocardium, with the ultimate aim of providing significant cardioprotection in the setting of acute MI.
Neuzil
Jiri
J
Apoptosis Research Group, Heart Foundation Research Centre, School of Medical Sciences, Griffith University, Southport, Queensland, Australia.
Rayner
Benjamin S
BS
Lowe
Harry C
HC
Witting
Paul K
PK
D000818:Animals; D003324:Coronary Artery Disease / Q000628:therapy*; D023903:Coronary Restenosis; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007511:Ischemia; D008954:Models, Biological; D015428:Myocardial Reperfusion Injury / Q000628:therapy; D016877:Oxidants / Q000378:metabolism; D018384:Oxidative Stress; D015427:Reperfusion Injury / Q000628:therapy; D013234:Stem Cells / Q000166:cytology; D016896:Treatment Outcome
D016877:Oxidants